This inventor holds 2 USPTO granted patents. Top assignee: Fujifilm Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Susumu Shimoyama: Innovator in Pharmaceutical Formulations
Introduction
Susumu Shimoyama is a notable inventor based in Ashigarakami-gun, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative use of liposome compositions.
Latest Patents
Shimoyama holds 2 patents that focus on combined pharmaceutical formulations. His first patent involves a formulation that combines a drug-containing liposome composition with an immune checkpoint inhibitor. This invention aims to enhance the efficacy of treatments by administering a liposome composition that encapsulates a drug alongside an immune checkpoint inhibitor. The liposome composition includes specific components such as a hydrophilic polymer-modified diacylphosphatidylethanolamine, dihydrosphingomyelin, and cholesterols, with a unique inner water phase containing ammonium sulfate.
His second patent also revolves around a combined pharmaceutical formulation, this time integrating a drug-containing liposome composition with a platinum preparation. Similar to his first patent, this formulation aims to improve therapeutic outcomes by utilizing a liposome composition that encapsulates a drug and is administered in conjunction with a platinum preparation.
Career Highlights
Shimoyama is currently associated with Fujifilm Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing advanced drug delivery systems that leverage liposome technology.
Collaborations
He has collaborated with notable coworkers, including Mikinaga Mori and Tadaaki Ioroi, contributing to the advancement of pharmaceutical research and development.
Conclusion
Susumu Shimoyama's contributions to pharmaceutical formulations through his innovative patents highlight his role as a key inventor in the field. His work continues to influence the development of effective drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
